A phase 2 trial in colorectal cancer, run by Charite University, Berlin, Germany, not yet recruiting.
Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors is a phase 2, interventional study registered as NCT04889742 by Charite University, Berlin, Germany, with a registry enrolment figure of 110 participants, started 2024-05-10 and due to reach its primary completion in 2026-01. Interventions recorded: loco-regional hyperthermia. Conditions listed: Recurrent Cancer; Prostate Cancer; Cervical Cancer; Anal Cancer; Sarcoma; Rectal Cancer; Neuroendocrine Tumors; Esophageal Cancer; Pancreas Cancer; Squamous Cell Carcinoma. Primary outcome: Local tumor recurrence. Sites: Germany. No results are recorded here; the registry entry is the source.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.